Further evidence of association between amphetamine response and SLC6A2 gene variants

Psychopharmacology

Volumn 206, Issue 3, 2009, Pages 501-511

  Dlugos, Andrea M ^a   Hamidovic, Ajna ^a   Palmer, Abraham A ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamine; Gene; Human; Norepinephrine; Reward; Transporter

Indexed keywords

AMPHETAMINE; PLACEBO; SEROTONIN PLASMA MEMBRANE TRANSPORTER PROTEIN A2; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; ENERGY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALE; MENTAL HEALTH; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 70349561331     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1628-y     Document Type: Article

References (48)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington
2. J Biederman T Spencer 1999 Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder Biol Psychiatry 46 1234 1242 10560028 10.1016/S0006-3223(99)00192-4 1:CAS:528:DyaK1MXotVOktrk%3D (Pubitemid 30114440)
3. M Böhm M Castellano M Flesch C Maack M Moll M Paul F Schiffer O Zolk 1998 Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophy Hypertension 32 831 837 9822440
4. LH Brauer H de Wit 1996 Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal healthy volunteers Biol Psychiatry 39 26 32 8719123 10.1016/0006-3223(95)00110-7 1:CAS:528:DyaK28XhtF2jtL0%3D (Pubitemid 26024199)
5. K Brookes X Xu W Chen K Zhou B Neale N Lowe 2006 The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes Mol Psychiatry 11 934 953 16894395 10.1038/sj.mp.4001869 1:CAS:528:DC%2BD28XhtVSnsrfE (Pubitemid 44470216)
6. CH Cheng GF Wooten 1982 Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites J Pharmacol Methods 8 123 133 7144209 10.1016/0160-5402(82)90066-3 1:CAS:528:DyaL3sXmsFKjsA%3D%3D
7. DE Comings D Muhleman R Gade P Johnson R Verde G Saucier G MacMurray 1997 Cannabinoid receptor gene (CNR1) association with i.v. drug use Mol Psychiatry 2 161 168 9106242 10.1038/sj.mp.4000247 1:STN:280:DyaK2s3mtVWntQ%3D%3D
8. JC Crabbe LF Jarvik EH Liston DJ Jenden 1983 Behavioral responses to amphetamine in identical twins Acta Genet Med Gemellol (Roma) 32 139 149 1:STN:280:DyaL2c%2Fns1Wjuw%3D%3D
9. H de Wit EH Uhlenhuth CE Johanson 1986 Individual differences in the reinforcing and subjective effects of amphetamine and diazepam Drug Alcohol Depend 196 341 360
10. A Dlugos C Freitag C Hohoff J McDonald EH Cook J Deckert H de Wit 2007 Norepinephrine transporter gene variation modulates acute response to d-amphetamine Biol Psychiatry 61 1296 1305 17239355 10.1016/j.biopsych.2006.09. 031 1:CAS:528:DC%2BD2sXls1aisro%3D (Pubitemid 46726264)
11. M Esler G Jackman A Bobik P Leonard D Kelleher H Skews G Jennings P Korner 1981 Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients Hypertension 3 149 156 7216371 1:STN:280:DyaL3M7ms1Kqsg%3D%3D
12. DM Fergusson LJ Horwood MT Lynskey PA Madden 2003 Early reactions to cannabis predict later dependence Arch Gen Psychiatry 60 1033 1039 14557149 10.1001/archpsyc.60.10.1033 (Pubitemid 37222087)
13. RR Gainetdinov WC Wetsel SR Jones ED Levin M Jaber MG Caron 1999 Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 397 401 9888856 10.1126/science.283.5400.397 1:CAS:528: DyaK1MXns1CitQ%3D%3D (Pubitemid 29045293)
14. LL Greenhill S Pliszka MK Dulcan W Bernet V Arnold J Beitchmann 2002 Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 41 26 49 10.1097/00004583-200210000-00003
15. CA Haertzen TR Kocher K Miyasato 1983 Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine Drug Alcohol Depend 11 147 165 6134605 10.1016/0376-8716(83)90076-5 1:STN:280:DyaL3s3jsVSntQ%3D%3D
16. C Heim CB Nemeroff 2001 The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies Biol Psychiatry 49 1023 1039 11430844 10.1016/S0006-3223(01)01157-X 1:STN:280: DC%2BD3MznsVCgtQ%3D%3D (Pubitemid 32595461)
17. CA Hodgkinson Q Yuan K Xu PH Shen E Heinz EA Lobos EB Binder J Cubells CL Ehlers J Gelernter J Mann B Riley A Roy B Tabakoff RD Todd Z Zhou D Goldman 2008 Addictions biology: haplotype-based analysis for 130 candidate genes on a single array Alcohol Alcohol 43 505 515 18477577 1:CAS:528:DC%2BD1cXhtF2rtbjE
18. C Hohoff JM McDonald BT Baune EH Cook J Deckert H de Wit 2005 Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants Am J Med Genet B Neuropsychiatr Genet 139B 42 44 16118787 10.1002/ajmg.b.30228 1:CAS:528:DC%2BD2sXms1yjtLs%3D (Pubitemid 41552296)
19. AS Horn 1973 Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues J Neurochem 21 883 888 4754864 10.1111/j.1471-4159.1973.tb07533.x 1:CAS:528:DyaE2cXlsFKluw%3D%3D
20. K Inoue K Itoh K Yoshida T Shimizu T Suzuki 2004 Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population Neuropsychobiology 50 301 304 15539861 10.1159/000080957 1:CAS:528: DC%2BD2cXpslWitrw%3D (Pubitemid 39482669)
21. CE Johanson EH Uhlenhuth 1980 Drug preference and mood in humans: diazepam Psychopharmacology (Berl) 71 269 273 10.1007/BF00433061 1:CAS:528:DyaL3MXlvVCitQ%3D%3D (Pubitemid 11194003)
22. H Kim DP Mittal MJ Ladarola RA Dionne 2006 Genetic predictors for acute experimental cold and heat pain sensitivity in humans J Med Genet 43 e40 16882734 10.1136/jmg.2005.036079 1:STN:280:DC%2BD28vlvFOiug%3D%3D
23. JW Kim J Biederman CL McGrath AE Doyle E Mick J Fagerness S Purcell JW Smoller P Sklar SV Faraone 2008 Further evidence of association between two NET single-nucleotide polymorphisms with ADHD Mol Psychiatry 13 624 630 17876324 10.1038/sj.mp.4002090 1:CAS:528:DC%2BD1cXlvFOjt7o%3D (Pubitemid 351704937)
24. A Kirley N Lowe Z Hawi C Mullins G Daly I Waldman M McCarron D O'Donnell M Fitzgerald M Gill 2003 Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD Am J Med Genet B Neuropsychiatr Genet 121B 50 54 12898575 10.1002/ajmg.b.20071
25. SH Kollins AD Anastopoulos AM Lachiewicz D Fitzgerald E Morrissey-Kane ME Garrett SL Keatts AE Ashley-Koch 2008 SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families Am J Med Genet B Neuropsychiatr Genet 147B 1580 1588 18821566 10.1002/ajmg.b.30876 1:CAS:528:DC%2BD1cXhsFWktLnF
26. YJ Lee C Hohoff K Domschke P Sand G Kuhlenbäumer A Schirmacher CM Freitag J Meyer G Stöber P Franke MM Nöthen J Fritze R Fimmers HS Garritsen F Stögbauer J Deckert 2005 Norepinephrine transporter (NET) promoter and 5'-UTR polymorphisms: association analysis in panic disorder Neurosci Lett 377 40 43 15722184 10.1016/j.neulet.2004.11.063 1:CAS:528:DC%2BD2MXhslCitrc%3D (Pubitemid 40255636)
27. BE Leonard 1997 The role of noradrenaline in depression: a review J Psychopharmacol 11 39 47
28. DC Lott S Kim EH Cook Jr H de Wit 2005 Dopamine transporter gene associated with diminished subjective response to amphetamine Neuropsychopharmacology 30 602 609 15602501 10.1038/sj.npp.1300637 1:CAS:528:DC%2BD2MXhtlOrt7k%3D (Pubitemid 40271162)
29. DC Lott SJ Kim EH Cook H de Wit 2006 Serotonin transporter genotype and acute subjective response to amphetamine Am J Addict 15 327 335 16966188 10.1080/10550490600859868 (Pubitemid 44373578)
30. WR Martin JW Sloan JD Sapira DR Jasinski 1971 Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 245 258 5554941 1:CAS:528:DyaE3MXhtl2gtLw%3D
31. McNair D, Lorr M, Droppleman DL (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego
32. P Merlet F Pouillart JL Dubois-Rande N Delhaye R Fumey A Castaigne A Syrota 1999 Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart J Nucl Med 40 224 231 10025827 1:STN:280:DyaK1M7kvVKqtg%3D%3D
33. JI Nurnberger Jr ES Gershon S Simmons M Ebert LR Kessler ED Dibble SS Jimerson GM Brown P Gold DC Jimerson JJ Guroff FI Storch 1982 Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and "well-state" bipolar patients Psychoneuroendocrinology 7 163 176 6891082 10.1016/0306-4530(82)90009-9 1:CAS:528:DyaL3sXislyrsQ%3D%3D
34. AA Palmer M Verbitsky R Suresh HM Kamens CL Reed N Li S Burkhart-Kasch CS McKinnon JK Belknap TC Gilliam TJ Phillips 2005 Gene expression differences in mice divergently selected for methamphetamine sensitivity Mamm Genome 16 291 305 16104378 10.1007/s00335-004-2451-8 1:CAS:528:DC%2BD2MXmtleksrw%3D (Pubitemid 41160333)
35. PV Piazza JM Deminière M Le Moal H Simon 1989 Factors that predict individual vulnerability to amphetamine self-administration Science 245 511 513 10.1126/science.2781295
36. JK Pritchard M Stephens P Donnelly 2000 Inference of population structure using multilocus genotype data Genetics 155 945 959 10835412 1:STN:280:DC%2BD3cvislKrtA%3D%3D
37. M Raiteri R Del Carmine A Bertollini G Levi 1977 Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine Eur J Pharmacol 41 133 143 832672 10.1016/0014-2999(77) 90202-3 1:CAS:528:DyaE2sXhtVSktbk%3D (Pubitemid 8015308)
38. KJ Ressler CB Nemeroff 1999 Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol Psychiatry 46 1219 1233 10560027 10.1016/S0006-3223(99)00127-4 1:CAS:528:DyaK1MXotVOktrg%3D (Pubitemid 30114439)
39. V Ricca E Mannucci A Paionni M Di Bernardo M Cellini PL Cabras CM Rotella 1999 Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study Eat Weight Disord 4 10 14 10728173 1:STN:280:DC%2BD3c7pt1CitQ%3D%3D
40. F Runkel M Brüss MM Nöthen G Stöber P Propping H Bönisch 2000 Pharmacological properties of naturally occurring variants of the human norepinephrine transporter Pharmacogenetics 10 397 405 10898109 10.1097/00008571-200007000-00003 1:CAS:528:DC%2BD3cXlt1yjs70%3D (Pubitemid 30433573)
41. TJ Spencer HB Abikoff DF Connor J Biederman SR Pliszka S Boellner SC Read R Pratt 2006 Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study Clin Ther 28 402 418 16750455 10.1016/j.clinthera.2006.03.006 1:CAS:528:DC%2BD28XmtlKgu7k%3D (Pubitemid 44218954)
42. D Taylor BT Ho 1978 Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine Res Commun Chem Pathol Pharmacol 21 67 75 684280 1:CAS:528:DyaE1cXlsFOhsLw%3D
43. J Veenstra-VanderWeele A Qaadir AA Palmer EH Cook Jr H de Wit 2006 Association between the casein kinase 1 epsilon gene region and subjective response to d-amphetamine Neuropsychopharmacology 31 1056 1063 16237383 10.1038/sj.npp.1300936 1:CAS:528:DC%2BD28XjsFahur8%3D
44. NP Verhoeff BK Christensen D Hussey M Lee G Papatheodorou L Kopala Q Rui RB Zipursky S Kapur 2003 Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study Pharmacol Biochem Behav 74 425 432 12479964 10.1016/S0091-3057(02)01028-6 1:CAS:528:DC%2BD38XptlGitLw%3D (Pubitemid 35449529)
45. TL White AJ Justice H de Wit 2002 Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase Pharmacol Biochem Behav 73 729 741 12213517 10.1016/S0091-3057(02)00818-3 1:CAS:528:DC%2BD38Xms1yls7Y%3D (Pubitemid 35251831)
46. S Williamson M Gossop B Powis P Griffiths J Fountain J Sttrang 1997 Adverse effects of stimulant drugs in a community sample of drug users Drug Alcohol Depend 44 87 94 9088780 10.1016/S0376-8716(96)01324-5 1:STN:280:DyaK2s3ktl2nuw%3D%3D (Pubitemid 27129501)
47. Xu X, Hawi Z, Brookes KJ, Anney R, Bellgrove M, Franke B, Barry E, Chen W, Kuntsi J, Banaschweski T, Buitelaar J, Ebstein R, Fitzgerald M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Gill M, Asherson P (2008) Replication of a rare protective allele in the noradrenaline transporter gene and ADHD. Am J Med Genet B Neuropsychiatr Genet 147B:1564-1567
48. L Yang YF Wang J Li SV Faraone 2004 Association of norepinephrine transporter gene with methylphenidate response J Am Acad Child Adolesc Psychiatry 43 1154 1158 15322419 10.1097/01.chi.0000131134.63368.46 (Pubitemid 39096873)